Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

A small molecule enhances RNA interference and promotes microRNA processing

Abstract

Small interfering RNAs (siRNAs) and microRNAs (miRNAs) are sequence-specific post-transcriptional regulators of gene expression. Although major components of the RNA interference (RNAi) pathway have been identified, regulatory mechanisms for this pathway remain largely unknown. Here we demonstrate that the RNAi pathway can be modulated intracellularly by small molecules. We have developed a cell-based assay to monitor the activity of the RNAi pathway and find that the small-molecule enoxacin (Penetrex) enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. We show that this RNAi-enhancing activity depends on the trans-activation-responsive region RNA-binding protein. Our results provide a proof-of-principle demonstration that small molecules can be used to modulate the activity of the RNAi pathway. RNAi enhancers may be useful in the development of research tools and therapeutics.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Identification of a small molecule enhancing RNAi through a chemical screen.
Figure 2: Enoxacin potentiates additional synthetic siRNA-induced gene knockdown.
Figure 3: Determination of chemical structure required for RNAi-enhancing activity.
Figure 4: Enoxacin promotes the processing of miRNAs and the loading of siRNA duplexes onto RISCs.
Figure 5: Enoxacin facilitates the TRBP-RNA interaction, and the RNAi-enhancing activity is TRBP-dependent.
Figure 6: Enoxacin enhances RNAi in vivo.

Similar content being viewed by others

References

  1. Hannon, G.J. RNA interference. Nature 418, 244–251 (2002).

    Article  CAS  Google Scholar 

  2. Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004).

    Article  CAS  Google Scholar 

  3. Plasterk, R.H. Micro RNAs in animal development. Cell 124, 877–881 (2006).

    Article  CAS  Google Scholar 

  4. Zamore, P.D. & Haley, B. Ribo-gnome: the big world of small RNAs. Science 309, 1519–1524 (2005).

    Article  CAS  Google Scholar 

  5. Dykxhoorn, D.M. & Lieberman, J. The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu. Rev. Med. 56, 401–423 (2005).

    Article  CAS  Google Scholar 

  6. Dykxhoorn, D.M. & Lieberman, J. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs. Annu. Rev. Biomed. Eng. 8, 377–402 (2006).

    Article  CAS  Google Scholar 

  7. Tiscornia, G., Singer, O., Ikawa, M. & Verma, I.M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. USA 100, 1844–1848 (2003).

    Article  CAS  Google Scholar 

  8. Hutvagner, G., Simard, M.J., Mello, C.C. & Zamore, P.D. Sequence-specific inhibition of small RNA function. PLoS Biol. 2, E98 (2004).

    Article  Google Scholar 

  9. Patel, S.S. & Spencer, C.M. Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections. Drugs 51, 137–160 (1996).

    Article  CAS  Google Scholar 

  10. Pasquinelli, A.E. Demystifying small RNA pathways. Dev. Cell 10, 419–424 (2006).

    Article  CAS  Google Scholar 

  11. Bhanot, S.K., Singh, M. & Chatterjee, N.R. The chemical and biological aspects of fluoroquinolones: reality and dreams. Curr. Pharm. Des. 7, 311–335 (2001).

    Article  CAS  Google Scholar 

  12. Hopper, D.C. & Wolfson, J.S. Quinolone Antimicrobial Agents 3rd edn. (ASM Press, Washington, DC; 2003).

    Google Scholar 

  13. Mitscher, L.A. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents. Chem. Rev. 105, 559–592 (2005).

    Article  CAS  Google Scholar 

  14. Schaeffer, A.J. The expanding role of fluoroquinolones. Am. J. Med. 113 Suppl 1A, 45S–54S (2002).

    Article  CAS  Google Scholar 

  15. Dalhoff, A. & Shalit, I. Immunomodulatory effects of quinolones. Lancet Infect. Dis. 3, 359–371 (2003).

    Article  CAS  Google Scholar 

  16. Eriksson, E., Forsgren, A. & Riesbeck, K. Several gene programs are induced in ciprofloxacin-treated human lymphocytes as revealed by microarray analysis. J. Leukoc. Biol. 74, 456–463 (2003).

    Article  CAS  Google Scholar 

  17. Rand, T.A., Ginalski, K., Grishin, N.V. & Wang, X. Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity. Proc. Natl. Acad. Sci. USA 101, 14385–14389 (2004).

    Article  CAS  Google Scholar 

  18. Liu, J. et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305, 1437–1441 (2004).

    Article  CAS  Google Scholar 

  19. Bernstein, E., Caudy, A.A., Hammond, S.M. & Hannon, G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363–366 (2001).

    Article  CAS  Google Scholar 

  20. Chendrimada, T.P. et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436, 740–744 (2005).

    Article  CAS  Google Scholar 

  21. Jiang, F. et al. Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila. Genes Dev. 19, 1674–1679 (2005).

    Article  CAS  Google Scholar 

  22. Forstemann, K. et al. Normal microRNA maturation and germ-line stem cell maintenance requires Loquacious, a double-stranded RNA-binding domain protein. PLoS Biol. 3, e236 (2005).

    Article  Google Scholar 

  23. Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T. & Nishimune, Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407, 313–319 (1997).

    Article  CAS  Google Scholar 

  24. Jackson, A.L. et al. Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity. RNA 12, 1179–1187 (2006).

    Article  CAS  Google Scholar 

  25. Lim, L.P. et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769–773 (2005).

    Article  CAS  Google Scholar 

  26. Jing, Q. et al. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120, 623–634 (2005).

    Article  CAS  Google Scholar 

  27. Katoh, T. & Suzuki, T. Specific residues at every third position of siRNA shape its efficient RNAi activity. Nucleic Acids Res. 35, e27 (2007).

    Article  Google Scholar 

  28. Duan, R., Pak, C. & Jin, P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum. Mol. Genet. 16, 1124–1131 (2007).

    Article  CAS  Google Scholar 

  29. Chu, C.Y. & Rana, T.M. Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54. PLoS Biol. 4, e210 (2006).

    Article  Google Scholar 

  30. Hutvagner, G. & Zamore, P.D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 297, 2056–2060 (2002).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank S. Warren, S. Chang, K. Garber and C. Strauss for their helpful discussions and critical reading of the manuscript and H. Ju for technical assistance. We thank I. Verma, J. Belasco and G. Hannon for providing us the plasmids. Q.L. is a Damon Runyon Scholar (DRS-43) and is supported by the Welch Foundation (I-1608). P.J. is supported by NIH grants (NS051630 and MH076090). P.J. is the recipient of a Beckman Young Investigator Award and a Basil O'Connor Scholar Research Award and is an Alfred P. Sloan Research Fellow in Neuroscience.

Author information

Authors and Affiliations

Authors

Contributions

P.J. designed the research. G.S. conducted the chemical screen and identified the small molecule presented in this paper. G.S. and Y.L. performed the majority of mechanistic experiments. J.Z., L.L., Z.S. and C.H. performed chemical synthesis. G.S., Y.L., W.L., M.A.F., A.M.K. and C.W. performed additional testing on the compound. K.E.S. and R.D. performed miRNA profiling and developed the reporter system. A.W.S.C., Z.P. and Q.L. provided some reagents used in this paper. G.S., Y.L. and P.J. wrote the paper.

Corresponding author

Correspondence to Peng Jin.

Ethics declarations

Competing interests

P.J. is the scientific founder of Effigene Pharmaceuticals, Inc. Effigene is engaged in the development of RNAi modulators.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–9, Tables 1–4, Methods (PDF 3440 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shan, G., Li, Y., Zhang, J. et al. A small molecule enhances RNA interference and promotes microRNA processing. Nat Biotechnol 26, 933–940 (2008). https://doi.org/10.1038/nbt.1481

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.1481

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing